Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population-Reference-Cited by-同舟云学术

Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population

Published:2002-05 Issue:5 Volume:57 Page:446-448
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Buc D.,Izakovicova Holla L.,Vacha J.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1398-9995.2002.03582.x/fullpdf

Reference12 articles.

1. Genetic and environmental interaction in allergy and asthma☆☆☆

2. Production of Plasminogen Activator Inhibitor-1 by Human Mast Cells and Its Possible Role in Asthma

3. PAI-1 Plasma Levels in a General Population Without Clinical Evidence of Atherosclerosis

4. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog;BioTech;2023-10-30

2. The 4G/5G polymorphism of plasminogen activator inhibitor type 1 is a predictor of allergic cough;Frontiers in Genetics;2023-02-24

3. The Intrinsically Disordered Loop in the USF1 bHLHZ Domain Modulates Its DNA-Binding Sequence Specificity in Hereditary Asthma;The Journal of Physical Chemistry B;2019-10-31

4. A review on the pathophysiology of asthma remission;Pharmacology & Therapeutics;2019-09

5. Association of PAI-1 4G/5G Polymorphism with Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus;Genetic Testing and Molecular Biomarkers;2018-09